Z. A. Sozaeva

Cognitive impairment in patients with treatment resistant schizophrenia: Associations with DRD2, DRD3, HTR2A, BDNF and CYP2D6 genetic polymorphisms

K. Ryzhikova, D. Ivashchenko, E. Grishina, 2019, Neurology, Psychiatry and Brain Research.

The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes

E. Grishina, D. Andreev, K. Mirzaev, 2018, Drug metabolism and personalized therapy.

FREQUENCY OF CYP2C19 AND ABCB1 GENES POLYMORPHISMS, ASSOCIATED WITH THE CHANGE, CAUSED BY CLOPIDOGREL ANTIAGREGANT AMONG THE RUSSIANS AND THE BURYATS

D. Sychev, K. Mirzaev, Shprakh Vv, 2018 .

PGPM_A_217725 329..339

K. Ryzhikova, E. Grishina, D. Sychev, 2019 .

Effect of polymorphisms in CYP3A4*22 (rs35599367) C>T, CYP3A5*3 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results

Федина, A. S. Osipov, K. Mirzaev, 2021, Meditsinskiy sovet = Medical Council.

Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma

M. Zastrozhin, D. Ivashchenko, E. Grishina, 2022, Drug metabolism and personalized therapy.

[Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome].

E. Grishina, D. Sychev, A. Kachanova, 2022, Terapevticheskii arkhiv.